Advaxis, Inc.

Advaxis, Inc.

Sector: Pharmaceutical Preparations Region: NJ, United States

: | Nasdaq: ADXS | Nasdaq: ADXSW

Similar to: BioAlliance Pharma SA, United-Guardian, Inc., Ipsen SA

Advaxis, Inc. is a clinical-stage biotechnology company, which intends to develop immunotherapies for cancer and infectious diseases. The company's platform technology is designed to generate a comprehensive immune response by serving as its own adjuvant, directing antigen presentation, increasing tumor infiltrating killer T-cells, and decreasing Tregs/MDSCs in the tumor. Advaxis was founded on June 5, 1987 and is headquartered in Princeton, NJ.

News & Analysis

You may also be interested in: